Brii Biosciences Limited (BRIBF)
USD 0.18
(46.03%)
USD 0.18
(46.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -486.49 Million CNY | 58.7% |
| 2022 | -1.17 Billion CNY | 58.43% |
| 2021 | -2.83 Billion CNY | -181.48% |
| 2020 | -1 Billion CNY | -19.09% |
| 2019 | -845.24 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -656.25 Million CNY | -34.89% |
| 2024 Q2 | -656.25 Million CNY | 0.29% |
| 2023 Q2 | -479.49 Million CNY | 1.64% |
| 2023 FY | -486.49 Million CNY | 58.7% |
| 2023 Q4 | -486.49 Million CNY | 0.64% |
| 2023 Q1 | -487.49 Million CNY | 58.61% |
| 2023 Q3 | -489.65 Million CNY | -2.12% |
| 2022 Q1 | -2.95 Billion CNY | -4.39% |
| 2022 FY | -1.17 Billion CNY | 58.43% |
| 2022 Q4 | -1.17 Billion CNY | 0.8% |
| 2022 Q3 | -1.18 Billion CNY | 59.73% |
| 2022 Q2 | -2.94 Billion CNY | 0.31% |
| 2021 Q1 | 4.69 Billion CNY | 566.75% |
| 2021 FY | -2.83 Billion CNY | -181.48% |
| 2021 Q2 | -1.41 Billion CNY | -130.17% |
| 2021 Q3 | -2.84 Billion CNY | -100.54% |
| 2021 Q4 | -2.83 Billion CNY | 0.32% |
| 2020 Q1 | 880.35 Million CNY | 0.0% |
| 2020 FY | -1 Billion CNY | -19.09% |
| 2020 Q4 | -1 Billion CNY | -172.51% |
| 2020 Q3 | 1.38 Billion CNY | 0.0% |
| 2019 FY | -845.24 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Qrons Inc. | 351.42 Thousand USD | 138533.871% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -7616.586% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -194793.839% |
| Adynxx, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 2448854.216% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 2499.359% |
| BioStem Technologies, Inc. | 4.47 Million USD | 10978.641% |
| CSL Limited | 10.52 Billion USD | 104.622% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 8712.998% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 1236.854% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 1220.076% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 76693.085% |
| Skye Bioscience, Inc. | -5.72 Million USD | -8403.075% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -2383739.671% |
| Rebus Holdings, Inc. | 305 Thousand USD | 159606.23% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -37136846.565% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 78268.724% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 3186.303% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 11913.773% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 121163.882% |
| SQZ Biotechnologies Company | -36.23 Million USD | -1242.497% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 21796.853% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 52569.947% |
| Mesoblast Limited | 55.85 Million USD | 970.944% |
| Marizyme, Inc. | 18.56 Million USD | 2719.922% |
| Genus plc | 190.6 Million USD | 355.243% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 21858.969% |
| Pharming Group N.V. | 109.8 Million USD | 543.057% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 56653.222% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 40177.338% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 71643.235% |
| ContraFect Corporation | -6.02 Million USD | -7973.249% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 361432.155% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 42205.054% |
| IMV Inc. | 7.67 Million USD | 6442.385% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 8942.297% |
| MultiCell Technologies, Inc. | 90.04 USD | 540308851.666% |
| ONE Bio Corp. | 9.04 Million USD | 5481.55% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -66181.823% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 3857.871% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 35663.181% |
| Q BioMed Inc. | 4.06 Million USD | 12082.587% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 1692.243% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 48376.895% |
| Biomind Labs Inc. | 711.4 Thousand USD | 68485.245% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 903.515% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 24432.097% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 3898.779% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 135346.171% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 348082.89% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 22193.469% |
| GB Sciences, Inc. | 1.74 Million USD | 27942.359% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -264603.898% |
| HST Global, Inc. | 96.79 Thousand USD | 502712.792% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 236013.625% |
| Halberd Corporation | 144.72 Thousand USD | 336259.922% |
| Enzolytics Inc. | 981.65 Thousand USD | 49658.501% |
| Agentix Corp. | 37.63 Thousand USD | 1292901.148% |
| Resverlogix Corp. | 6.45 Million USD | 7641.373% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -72177.812% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 76.021% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | -934.829% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 6980.157% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 18060.987% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -5403.381% |
| AVAX Technologies, Inc. | -5.9 Million USD | -8141.181% |
| Zenith Capital Corp. | 10.06 Thousand USD | 4834102.385% |
| Genscript Biotech Corporation | -1.06 Billion USD | 54.162% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 242822.719% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 20489.232% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 295824.854% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -2655724.872% |
| Kadimastem Ltd | -253.1 Thousand USD | -192112.626% |
| Helix BioMedix, Inc. | -2.57 Million USD | -18829.492% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 241831.344% |
| LadRx Corporation | -2.03 Million USD | -23789.094% |
| Cell Source, Inc. | 9.23 Million USD | 5369.666% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 76693.085% |
| NovAccess Global Inc. | 2.17 Million USD | 22431.963% |
| Affymax, Inc. | -5.59 Million USD | -8592.049% |
| Itoco Inc. | 228.3 Thousand USD | 213189.507% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 357845.112% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 9914.283% |
| Mobile Lads Corp. | 484.23 Thousand USD | 100567.131% |
| CytoDyn Inc. | 20.26 Million USD | 2501.017% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -75192172.025% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -5248887.413% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 6413.183% |
| SYBLEU INC | 473.71 Thousand USD | 102797.83% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 11015.225% |
| International Stem Cell Corporation | 2.59 Million USD | 18883.552% |
| Bioxytran, Inc. | 1.89 Million USD | 25719.591% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 779575.43% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 22407.029% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 14266.977% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 5787.993% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 63067.848% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -38819.52% |
| Neutra Corp. | 52.18 Thousand USD | 932313.003% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -19445.761% |
| PureTech Health plc | -167.19 Million USD | -190.971% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -198543.572% |
| IXICO plc | -4.44 Million USD | -10845.764% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 3780.263% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 986.937% |
| CSL Limited | 10.52 Billion USD | 104.622% |
| Cellectis S.A. | -43.81 Million USD | -1010.239% |